Catalyst Wire Dossier Catalyst Wire Dossier

Nurzigma

pridopidine hydrochloride · Prilenia Therapeutics B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nurzigma, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: EMA Application withdrawn: Nurzigma (pridopidine hydrochloride) — Prilenia Therapeutics B.V.

See pricing